Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular Recanalization Versus Aggressive Medical Management Alone for Symptomatic Non-Acute Intracranial Artery Occlusion
NCT07495969Not yet recruiting
- Sponsor
- FengGao
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in intracranial arterial occlusion (IAO) and ischemic stroke (2 arms), sponsored by FengGao. Primary endpoint: Composite of any stroke or death within 30 days, or ischemic stroke in the same region between 30 days and 1 year. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
intracranial arterial occlusion (IAO)ischemic stroke
Beyond the preview
Go deeper on NCT07495969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07495969.